PUBLISHER: AnalystView Market Insights | PRODUCT CODE: 1425006
PUBLISHER: AnalystView Market Insights | PRODUCT CODE: 1425006
ECG Telemetry Devices Market size was valued at USD 5,344.2 Million in 2022, expanding at a CAGR of 6.3% from 2023 to 2030.
An ECG telemetry device is a valuable tool used to monitor and record the heart's electrical activity, translating it into a waveform that can detect cardiac abnormalities and evaluate the effectiveness of treatments or interventions. Several key factors are driving the growth of the ECG telemetry device market.
ECG Telemetry Devices Market- Market Dynamics
Increasing prevalence of cardiovascular diseases, which has been exacerbated by factors such as lifestyle changes and an aging population is expected to propel the market demand
The market for ECG Telemetry devices is driven by an increasing prevalence of cardiovascular diseases, which has been exacerbated by factors such as lifestyle changes and an aging population. For example, in the United Kingdom, a report from BHF in 2022 revealed that over 7.6 million people were living with cardiovascular diseases in 2021. This high prevalence of heart conditions is expected to drive the demand for regular heart monitoring, thus boosting the market. Additionally, the increasing occurrence of risk factors like obesity, diabetes, hypertension, and high cholesterol among the population is contributing to the expansion of the ECG telemetry device market. For instance, obesity rates are projected to increase significantly in the United States, Mexico, and Canada by 2030. Furthermore, the global diabetes population is expected to reach 783 million by 2045. These conditions can lead to high blood sugar levels, damaging the nerves that control the heart and blood vessels, which can result in various cardiovascular diseases. Consequently, there is a rising demand for cardiac event monitoring and other telemetry devices, further propelling market growth.
ECG Telemetry Devices Market- Key Insights
As per the analysis shared by our research analyst, the global ECG Telemetry Devices Market is estimated to grow annually at a CAGR of around 6.3% over the forecast period (2023-2030)
The ECG Telemetry Devices Market is projected to grow at a significant rate driven by increasing prevalence of cardiovascular diseases, which has been exacerbated by factors such as lifestyle changes and an aging population
Based on product type, the Implantable Loop Recorders segment was predicted to show maximum market share in the year 2022
Based on Application, arrhythmias were the leading Segment in 2022
On the basis of region, North America was the leading revenue generator in 2022
The Global ECG Telemetry Devices Market is segmented on the basis of Product Type, By Application, and Region.
Based on product type, the market is divided into three segments: Event Monitoring and Mobile Cardiac Telemetry, Implantable Loop Recorders and Other Products. The implantable loop recorder (ILR) segment is poised for substantial growth in the ECG telemetry devices market during the forecast period. This growth can be attributed to several factors, including the rising prevalence of cardiac disorders, recent technological advancements in cardiac monitoring devices, and the increasing demand for remote patient monitoring. An implantable loop recorder, also known as a cardiac event recorder, is a heart-monitoring device that continuously records the heart's rhythm for up to three years while enabling remote monitoring by medical professionals. A December 2021 article in Cardiovascular Diagnosis and Therapy (CDT) highlights that ILRs offer significant supplementary diagnostic value in identifying and classifying benign and malignant arrhythmias in symptomatic CHD patients at risk of life-threatening cardiac events. The article also suggests that ILR implantation should be considered for CHD patients needing medium or long-term arrhythmia monitoring, especially when short-term Holter monitoring falls short in providing sufficient diagnostic certainty. These factors are expected to drive the adoption of implantable loop recorders among patients with various cardiovascular diseases, thus fueling the growth of this segment.
Based on application the ECG telemetry devices market is categorized into 4 applications: arrhythmias, myocardial ischemia and infarction, pacemaker monitoring, and other applications. The arrhythmias segment is projected to hold a significant market share in the upcoming years. This prominence can be attributed to the expected growth in the elderly population, which is more susceptible to cardiovascular disorders like arrhythmias. Arrhythmia is characterized by irregular heartbeats, where electrical impulses are either too fast or too slow, leading to decreased heart efficiency in pumping blood. ECG telemetry devices are considered the most effective tools for detecting arrhythmias.
ECG Telemetry Devices Market- Geographical Insights
Geographically, this market is widespread into the regions of North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. These regions are further divided as per the nations bringing business. North America is expected to dominate the market during the forecast period. The region's growing demand and acceptance of ECG telemetry devices, high healthcare costs and reimbursement regulations, and the population's increasing cardiovascular strain are all factors contributing to the market's growth.
Companies in the ECG telemetry market is actively engaged in developing and deploying innovative technologies to enhance remote cardiac monitoring and improve patient care. Major players such as Philips Healthcare, GE Healthcare, and Hillrom are focusing on the development of advanced ECG telemetry devices and software solutions to provide real-time monitoring, early detection of cardiac abnormalities, and seamless data transmission to healthcare providers. Additionally, there is a growing emphasis on the integration of telemetry systems with telehealth platforms, enabling healthcare professionals to remotely monitor patients and make timely interventions. Collaborations and partnerships between healthcare technology companies and medical institutions are becoming more common to expand the reach of ECG telemetry solutions and improve patient outcomes. These efforts reflect the industry's commitment to advancing the field of remote cardiac monitoring and ensuring the timely diagnosis and management of cardiac conditions.
In August 2022, Xoran Technologies obtained clearance from the USFDA (510(k)) for TRON, a mobile full-body ECG Telemetry Devices and computed tomography (CT) X-ray system. Tailored for constrained spaces such as operating rooms, surgery centers, and critical care units, TRON is an ideal solution providing secure, ultra-high-resolution, low-dose imaging.
In July 2022, Fujifilm Healthcare Americas Corporation, a provider of diagnostic and enterprise imaging solutions, introduced FDR Cross, an innovative hybrid c-arm and portable x-ray solution designed for use in hospitals and ambulatory surgery centers (ASC). This groundbreaking dual-function c-arm is the first of its kind to offer portable fluoroscopic and radiographic imaging capabilities on a single platform, eliminating the necessity for additional imaging equipment during vital image-guided procedures.